Setup, so nobody has to ask: hair thinning · a GLP-1 receptor agonist · STEP 3.
I would like help reading this properly rather than being told what conclusion to reach.
I have the full report including the method section, so I can quote specifics if that helps.
How should I read this, and where are the traps?
Take it from the STEP 3 adverse-event table by arm, and check the unit before you use it. An incidence can be the proportion of participants who reported the event at least once, or the count of events divided by exposure time, and the two differ by however many people had it repeatedly. Then subtract the placebo arm, because the untreated rate is not zero. And read the discontinuation column beside it: an event that made people leave the trial is under-counted at every later visit, so a low late-timepoint incidence can mean the event was severe rather than rare.
This is one of the most distressing reported effects and one of the most reliably temporary.
Nothing topical has strong evidence for accelerating recovery from telogen effluvium specifically, as distinct from androgenetic loss where the evidence is entirely different.
In telogen effluvium a stressor shifts a large fraction of follicles from anagen into telogen simultaneously. Because telogen lasts around two to three months, the shed appears two to four months after the trigger rather than during it.
Low ferritin is associated with increased shedding in observational studies at thresholds above those used to define anaemia.
The trigger is the rate of loss, not the compound. Slowing it helps future follicles.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsMechanically, patterned rather than diffuse loss is a different condition and points elsewhere.
The trigger in this context is the rate of weight loss and the associated nutritional deficit, not a pharmacological property. The same phenomenon is well documented after bariatric surgery, illness and childbirth.
Recovery follows the same timeline in reverse: shedding stops within a few months of the trigger resolving, and visible density returns over six to twelve months as regrowth reaches length.
Recovery of density over six to twelve months is the typical reported course where the trigger has resolved.
Nothing here is medical advice.
Check ferritin, thyroid and vitamin D once, then stop investigating.
In practice, iron, thyroid and vitamin D are the checks worth doing before concluding anything.
Adequate protein matters. Hair is largely keratin, and follicles are among the most metabolically active tissues, so they are early casualties of a substantial protein shortfall.
It is diffuse: increased shedding across the whole scalp, often noticed in the shower or on a brush, without a receding hairline or a defined crown pattern. Patterned loss is androgenetic and unrelated.
The caveat is that patterned loss, scalp inflammation, scarring or loss with other systemic symptoms is a dermatological problem and not this.
Protein intake is the modifiable nutritional factor worth attending to.
edited 16 Jun 2025 by tobias_maartens — tightened the wording; no substantive change
Answer first: the pattern reported here is telogen effluvium — a diffuse shed triggered by a physiological stressor — and rapid weight loss is a well-established trigger for it.
Worth checking: ferritin, thyroid function and vitamin D. Low ferritin in particular is associated with shedding at levels that are not low enough to cause anaemia.
The two-to-four-month latency follows directly from the duration of the telogen phase and is the diagnostic feature of the condition.
Research-use compounds are not approved for human use.
Diffuse and delayed means telogen effluvium. Patterned means something else.
Answering this needs the rate of weight loss and the protein intake, since those are the two modifiable contributors.
Slowing the rate of weight loss reduces the severity of the trigger. It does not reverse a shed already in progress, because the follicles have already committed.
Telogen effluvium following rapid weight loss is well documented in the dermatological literature, including extensive description after bariatric surgery.
Supplementing without a measured deficiency has no evidence behind it here and is not harmless at high doses.
It resolves in most cases over six to twelve months. That is genuinely the answer.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.